Paula Lorgelly
Overview
Explore the profile of Paula Lorgelly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
689
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Warren H, Wagner T, Gorin M, Rowe S, Holman B, Pencharz D, et al.
BMJ Open
. 2023 Jan;
13(1):e067496.
PMID: 36693694
Introduction: The incidence of renal tumours is increasing and anatomic imaging cannot reliably distinguish benign tumours from renal cell carcinoma. Up to 30% of renal tumours are benign, with oncocytomas...
12.
Dale C, Takhar R, Carragher R, Katsoulis M, Torabi F, Duffield S, et al.
Nat Med
. 2023 Jan;
29(1):219-225.
PMID: 36658423
How the Coronavirus Disease 2019 (COVID-19) pandemic has affected prevention and management of cardiovascular disease (CVD) is not fully understood. In this study, we used medication data as a proxy...
13.
Lorimer K, Greco G, Lorgelly P
Cult Health Sex
. 2022 Dec;
25(10):1402-1417.
PMID: 36565149
Over the last twenty years, there has been a growing interest in measuring sexual wellbeing, including by a WHO/UNFPA working group in 2007, which sought clarity on key dimensions and...
14.
Saygin Avsar T, Yang X, Lorgelly P
Pharmacoeconomics
. 2022 Dec;
41(2):123-138.
PMID: 36471131
Some researchers have argued that the aim of an economic evaluation should be to offer guidance on resource allocation based on public interest from a societal perspective. The application of...
15.
van der Feltz-Cornelis C, Sweetman J, Allsopp G, Attree E, Crooks M, Cuthbertson D, et al.
PLoS One
. 2022 Nov;
17(11):e0277936.
PMID: 36449461
Introduction: As mortality rates from COVID-19 disease fall, the high prevalence of long-term sequelae (Long COVID) is becoming increasingly widespread, challenging healthcare systems globally. Traditional pathways of care for Long...
16.
Ramasawmy M, Mu Y, Clutterbuck D, Pantelic M, Lip G, van der Feltz-Cornelis C, et al.
PLoS One
. 2022 Aug;
17(8):e0271978.
PMID: 35969597
Introduction: Individuals with Long Covid represent a new and growing patient population. In England, fewer than 90 Long Covid clinics deliver assessment and treatment informed by NICE guidelines. However, a...
17.
Jain V, Atun R, Hansen P, Lorgelly P
BMC Public Health
. 2022 Aug;
22(1):1518.
PMID: 35945545
Background: The COVID-19 pandemic and associated non-pharmaceutical interventions (NPIs) have affected all countries. With a scarcity of COVID-19 vaccines there has been a need to prioritize populations, but assessing relative...
18.
Jain V, Serisier A, Lorgelly P
Int J Public Health
. 2022 Jul;
67:1604793.
PMID: 35865144
Disease control is important to limit the social, economic and health effects of COVID-19 and reduce the risk of novel variants emerging. Evidence suggests vaccines are less effective against the...
19.
Fabes J, Saygin Avsar T, Spiro J, Fernandez T, Eilers H, Evans S, et al.
Appl Health Econ Health Policy
. 2022 May;
20(5):693-706.
PMID: 35606636
Background: Information asymmetries and the agency relationship are two defining features of the healthcare system. These market failures are often used as a rationale for government intervention. Many countries have...
20.
Li K, Lorgelly P, Jasim S, Morris T, Gomes M
Eur J Health Econ
. 2022 May;
24(2):179-186.
PMID: 35522390
While the negative impact of unemployment on health is relatively well established, the extent to which that impact reflects on changes in health and social care utilisation is not well...